Alvespimycin is identified as a novel therapeutic agent for diabetic kidney disease by chemical screening targeting extracellular vesicles

D Daisuke Fujimoto S Shuro Umemoto T Teruhiko Mizumoto T Tomoko Kanki Y Yusuke Hata Y Yoshihiko Nishiguchi R Ryosuke Date J Jingxuan Zhang Y Yutaka Kakizoe Y Yuichiro Izumi M Masataka Adachi H Hirotatsu Kojima H Hideki Yokoi M Masashi Mukoyama T Takashige Kuwabara

Article Details

Volume / Issue Vol. 15, Issue 1
Published April 25, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (15)

D

Daisuke Fujimoto

S

Shuro Umemoto

T

Teruhiko Mizumoto

T

Tomoko Kanki

Y

Yusuke Hata

Y

Yoshihiko Nishiguchi

R

Ryosuke Date

J

Jingxuan Zhang

Y

Yutaka Kakizoe

Y

Yuichiro Izumi

M

Masataka Adachi

H

Hirotatsu Kojima

H

Hideki Yokoi

M

Masashi Mukoyama

T

Takashige Kuwabara